CTLA4 and colitis: found that colitis induced by anti-CTLA-4 therapy is related to the composition of the gut microbiota, and the inflammation is caused by the unchecked activation of CD4+ T cells and the attenuation of Tregs through their interaction with the Fc domain of the CTLA-4 antibody (160).